These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33145590)

  • 1. Molecular Genetic Landscape of Sclerosing Pneumocytomas.
    Boland JM; Lee HE; Barr Fritcher EG; Voss JS; Jessen E; Davila JI; Kipp BR; Graham RP; Maleszewski JJ; Yi ES
    Am J Clin Pathol; 2021 Feb; 155(3):397-404. PubMed ID: 33145590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT1 internal tandem duplications and point mutations are the genetic hallmarks of sclerosing pneumocytoma.
    Yeh YC; Ho HL; Wu YC; Pan CC; Wang YC; Chou TY
    Mod Pathol; 2020 Mar; 33(3):391-403. PubMed ID: 31527710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Genomic and Transcriptomic Analysis of Sclerosing Pneumocytoma.
    Yeh YC; Chu PY; Lin SY; Wang SY; Ho HL; Wang YC
    Mod Pathol; 2024 Jan; 37(1):100354. PubMed ID: 37844870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the BRAF V600E mutation in a patient with sclerosing pneumocytoma: A case report.
    Jiang G; Zhang M; Tan Q; Lin S; Zeng Y; Liu C; Chen R; Zhou J
    Lung Cancer; 2019 Nov; 137():52-55. PubMed ID: 31546071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome profile in a extremely rare case of pulmonary sclerosing pneumocytoma presenting with diffusely-scattered nodules in the right lung.
    Fan X; Lin L; Wang J; Wang Y; Feng A; Nie L; Wu H; Meng F; Xu H
    Cancer Biol Ther; 2018 Jan; 19(1):13-19. PubMed ID: 29236566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected diagnosis of multiple sclerosing pneumocytomas in a patient with chondrosarcoma of the hand.
    Van Laer SL; Vandendriessche A; Somville J; Van Schil PE
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33495182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the PI3K/Akt, mTOR, and STK11/LKB1 pathways in the tumorigenesis of sclerosing hemangioma of the lung.
    Amin RM; Hiroshima K; Miyagi Y; Kokubo T; Hoshi K; Fujisawa T; Nakatani Y
    Pathol Int; 2008 Jan; 58(1):38-44. PubMed ID: 18067639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Akt/mammalian target of rapamycin/4E-binding protein 1 pathway signal activation in round stromal and surface cells in patients with sclerosing pneumocytoma.
    Hashisako M; Iwasaki T; Matsumoto T; Yamada Y; Miyamoto T; Taniguchi M; Oishi C; Oda Y
    Pathol Res Pract; 2023 Apr; 244():154384. PubMed ID: 36878109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
    Lim SM; Park HS; Kim S; Kim S; Ali SM; Greenbowe JR; Yang IS; Kwon NJ; Lee JL; Ryu MH; Ahn JH; Lee J; Lee MG; Kim HS; Kim H; Kim HR; Moon YW; Chung HC; Kim JH; Kang YK; Cho BC
    Oncotarget; 2016 Mar; 7(9):10547-56. PubMed ID: 26859683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
    Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J
    Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus-containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study.
    Chen Z; Zheng Y; Cao W; Zhang Y; Zhao Z; Wang G; Zhao J; Cai S; Shao X; Huang J; Ye W; Huang Y; Li W; Huang X; Wu H; Wang X; Yin Y
    Cancer Med; 2019 Sep; 8(12):5544-5553. PubMed ID: 31385461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation Profiling of Usual Ductal Hyperplasia of the Breast Reveals Activating Mutations Predominantly at Different Levels of the PI3K/AKT/mTOR Pathway.
    Jahn SW; Kashofer K; Thüringer A; Abete L; Winter E; Eidenhammer S; Viertler C; Tavassoli F; Moinfar F
    Am J Pathol; 2016 Jan; 186(1):15-23. PubMed ID: 26718977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
    Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.
    Roldan-Romero JM; Beuselinck B; Santos M; Rodriguez-Moreno JF; Lanillos J; Calsina B; Gutierrez A; Tang K; Lainez N; Puente J; Castellano D; Esteban E; Climent MA; Arranz JA; Albersen M; Oudard S; Couchy G; Caleiras E; Montero-Conde C; Cascón A; Robledo M; Rodríguez-Antona C; García-Donas J;
    Int J Cancer; 2020 Mar; 146(5):1435-1444. PubMed ID: 31335987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma.
    Chuang CK; Lin HCA; Tasi HY; Lee KH; Kao Y; Chuang FL; Chang YH; Lin PH; Liu CY; Pang ST
    Int Urol Nephrol; 2017 Sep; 49(9):1527-1536. PubMed ID: 28547571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and gene mutation analysis of clear cell tumor of the lung.
    Wu S; Pan D; Chen W; Ren F; Zheng D; Liu K
    Indian J Pathol Microbiol; 2021; 64(2):362-368. PubMed ID: 33851636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance.
    Vicentini C; Cantù C; Antonello D; Simbolo M; Mafficini A; Luchini C; Rusev B; Porcaro AB; Iacovelli R; Fassan M; Corbo V; Brunelli M; Artibani W; Scarpa A; Lawlor RT
    Pathol Res Pract; 2018 Oct; 214(10):1675-1680. PubMed ID: 30190183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustered pulmonary sclerosing pneumocytoma in a young man: a case report.
    Shin SY; Kim MY; Lee HJ; Oh SY; Jang SJ
    Clin Imaging; 2014; 38(4):532-535. PubMed ID: 24667045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
    Kim ST; Kim SY; Klempner SJ; Yoon J; Kim N; Ahn S; Bang H; Kim KM; Park W; Park SH; Park JO; Park YS; Lim HY; Lee SH; Park K; Kang WK; Lee J
    Ann Oncol; 2017 Mar; 28(3):547-554. PubMed ID: 28028034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.